BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:18 AM EDT
165.87quote price arrow down-4.90 (-2.87%)
Volume
129,745
Close
170.77quote price arrow down-6.11 (-3.45%)
Volume
8,764,516
52 week range
45.08 - 213.15

...

Loading . . .
  • Open185.41
  • Day High196.08
  • Day Low161.22
  • Prev Close170.77
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap41.244B
  • Shares Out241.52M
  • 10 Day Average Volume4.70M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change109.48

KEY STATS

  • Open185.41
  • Day High196.08
  • Day Low161.22
  • Prev Close170.77
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20
  • Market Cap41.244B
  • Shares Out241.52M
  • 10 Day Average Volume4.70M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change109.48

RATIOS/PROFITABILITY

  • EPS (TTM)-0.41
  • P/E (TTM)-419.79
  • Fwd P/E (NTM)6.62
  • EBITDA (MRQ)-52.464M
  • ROE (MRQ)1.63%
  • Revenue (MRQ)579.42M
  • Gross Margin (MRQ)87.70%
  • Net Margin (MRQ)3.15%
  • Debt To Equity (MRQ)17.29%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO0:5400:54
Biden administration supports waiver of patent protections for Covid vaccines

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
MRNA
Moderna Inc
162.84-10.75-6.19%
NVAX
Novavax Inc
171.74-8.93-4.94%
GMAB
Genmab A/S
36.68+1.09+3.06%
ALNY
Alnylam Pharmaceuticals Inc
132.67+1.10+0.84%
GH
Guardant Health Inc
139.73-8.46-5.71%